fxs_header_sponsor_anchor

News

US’ Fauci: US may not need AstraZeneca COVID-19 vaccine

Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), told Reuters on Thursday that the United States may not need AstraZeneca's COVID-19 vaccine, even if it wins U.S. regulatory approval.

“The vaccine, once hailed as another milestone in the fight against the COVID-19 pandemic, has been dogged by questions since late last year, even as it has been authorized for use by dozens of countries, not including the US,” said the news.

Additional comments from Dr. Fauci mentioned, "If you look at the numbers (of doses) that we're going to be getting, the amount that you can get from J&J, from Novavax from Moderna if we contract for more, it is likely that we can handle any boost that we need, but I can't say definitely for sure."

Elsewhere chatters also grew louder suggesting the US government is working on new travel guidance for vaccinated Americans and the same will be out by Friday. However, nothing key appeared strong during the dull Good Friday markets.

Market reaction

Given the holiday in multiple Asian markets, due to the Good Friday, there was a little reaction to the news that should have ideally weighed on the sentiment. That said, S&P 500 Futures print mild gains of 0.12% by the press time.

Read: Gold Price Analysis: XAU/USD bulls probed below $1,750 amid thin holiday trade

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.